Category:
Prophylactic Biological Products
CAS NO:
123246-29-7
Standard:
ChP,USP,EP,
Indications:
Mechanism of Action: Ganirelix works by competitively blocking the GnRH receptors on the pituitary gland, thus preventing the release of LH and follicle-stimulating hormone (FSH). This inhibition prevents premature ovulation, allowing for more controlled ovarian hyperstimulation.
Pharmacokinetics:
Form: Ganirelix API is typically presented as a white to off-white lyophilized powder.